
BiotechTV - News Jefferies London 2026: Valneva CEO Thomas Lingelbach shares an update on the status of the company's Lyme disease program (partnered with Pfizer) and more pipeline projects
Nov 17, 2026
Chapters
Transcript
Episode notes

BiotechTV - News